Your browser doesn't support javascript.
loading
Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening.
Joh, Hea Sun; Yeats, Corin; Shaw, Alina; Poudyal, Nimesh; Gallagher, Patrick; Kim, Jong-Hoon; Shaikh, Affan; Seo, Hye Jin; Chi, Kyu-Young Kevin; Prifti, Kristi; Cho, Alyssa; Sujan, Mohammad Julhas; Eraly, Emmanuel; Pham, Kien Duc; Shrestha, Subha; Aboushady, Ahmed Taha; Pak, Gideok; Jang, GeunHyeog; Park, Eun Lyeong; Seo, Hyeong-Won; Abudahab, Khalil; Taylor, Ben E W; Clark, Adam; Dolabella, Brooke; Yoon, Hyein; Han, Jihyun; Kwon, Soo Young; Marks, Florian; Stelling, John; Aanensen, David M; MacWright, William R; Holm, Marianne.
Afiliación
  • Joh HS; International Vaccine Institute, Seoul, Republic of Korea.
  • Yeats C; Centre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, United Kingdom.
  • Shaw A; Public Health Surveillance Group, LLC, Princeton, New Jersey, USA.
  • Poudyal N; International Vaccine Institute, Seoul, Republic of Korea.
  • Gallagher P; Public Health Surveillance Group, LLC, Princeton, New Jersey, USA.
  • Kim JH; International Vaccine Institute, Seoul, Republic of Korea.
  • Shaikh A; Public Health Surveillance Group, LLC, Princeton, New Jersey, USA.
  • Seo HJ; International Vaccine Institute, Seoul, Republic of Korea.
  • Chi KK; International Vaccine Institute, Seoul, Republic of Korea.
  • Prifti K; International Vaccine Institute, Seoul, Republic of Korea.
  • Cho A; International Vaccine Institute, Seoul, Republic of Korea.
  • Sujan MJ; International Vaccine Institute, Seoul, Republic of Korea.
  • Eraly E; International Vaccine Institute, Seoul, Republic of Korea.
  • Pham KD; International Vaccine Institute, Seoul, Republic of Korea.
  • Shrestha S; International Vaccine Institute, Seoul, Republic of Korea.
  • Aboushady AT; International Vaccine Institute, Seoul, Republic of Korea.
  • Pak G; Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Jang G; International Vaccine Institute, Seoul, Republic of Korea.
  • Park EL; International Vaccine Institute, Seoul, Republic of Korea.
  • Seo HW; International Vaccine Institute, Seoul, Republic of Korea.
  • Abudahab K; International Vaccine Institute, Seoul, Republic of Korea.
  • Taylor BEW; Centre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, United Kingdom.
  • Clark A; Centre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, United Kingdom.
  • Dolabella B; Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Yoon H; Public Health Surveillance Group, LLC, Princeton, New Jersey, USA.
  • Han J; International Vaccine Institute, Seoul, Republic of Korea.
  • Kwon SY; International Vaccine Institute, Seoul, Republic of Korea.
  • Marks F; International Vaccine Institute, Seoul, Republic of Korea.
  • Stelling J; International Vaccine Institute, Seoul, Republic of Korea.
  • Aanensen DM; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
  • MacWright WR; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
  • Holm M; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.
Clin Infect Dis ; 77(Suppl 7): S507-S518, 2023 12 20.
Article en En | MEDLINE | ID: mdl-38118007
ABSTRACT
Antimicrobial resistance (AMR) is a multifaceted global health problem disproportionately affecting low- and middle-income countries (LMICs). The Capturing data on Antimicrobial resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) project was tasked to expand the volume of AMR and antimicrobial use data in Asia. The CAPTURA project used 2 data-collection streams facility data and project metadata. Project metadata constituted information collected to map out data sources and assess data quality, while facility data referred to the retrospective data collected from healthcare facilities. A down-selection process, labelled "the funnel approach" by the project, was adopted to use the project metadata in prioritizing and selecting laboratories for retrospective AMR data collection. Moreover, the metadata served as a guide for understanding the AMR data once they were collected. The findings from CAPTURA's metadata add to the current discourse on the limitation of AMR data in LMICs. There is generally a low volume of AMR data generated as there is a lack of microbiology laboratories with sufficient antimicrobial susceptibility testing capacity. Many laboratories in Asia are still capturing data on paper, resulting in scattered or unused data not readily accessible or shareable for analyses. There is also a lack of clinical and epidemiological data captured, impeding interpretation and in-depth understanding of the AMR data. CAPTURA's experience in Asia suggests that there is a wide spectrum of capacity and capability of microbiology laboratories within a country and region. As local AMR surveillance is a crucial instrument to inform context-specific measures to combat AMR, it is important to understand and assess current capacity-building needs while implementing activities to enhance surveillance systems.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Países en Desarrollo / Antibacterianos Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Países en Desarrollo / Antibacterianos Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article